Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Bates

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Cancer Research|September 18, 2001
Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cellsY Honjo, C A Hrycyna, Q W Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Screening for and identification of novel agents directed at renal cell carcinomaS D Mertins, T G Myers, M Hollingshead, et al.
Molecular Endocrinology (Baltimore, Md.)|June 1, 1988
Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significanceS E Bates, N E Davidson, E M Valverius, et al.
Leukemia|May 24, 2007
Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cellsC Brendel, C Scharenberg, M Dohse, et al.
European Journal of Cancer (Oxford, England : 1990)|January 11, 2011
The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecanO Arnaud, A Boumendjel, A Gèze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapyW H Wilson, C Jamis-Dow, G Bryant, et al.
British Journal of Cancer|April 3, 2008
Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changesA M Calcagno, J M Fostel, K K W To, et al.
Breast Cancer Research and Treatment|September 14, 2016
ANG1005 for breast cancer brain metastases: correlation between <sup>18</sup>F-FLT-PET after first cycle and MRI in response assessmentC C O'Sullivan, M Lindenberg, C Bryla, et al.
Science (New York, N.Y.)|January 17, 1997
An information-intensive approach to the molecular pharmacology of cancerJ N Weinstein, T G Myers, P M O'Connor, et al.
Cancer Research|July 1, 1996
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendationsW T Beck, T M Grogan, C L Willman, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Cancer Research|September 18, 2001
Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cellsY Honjo, C A Hrycyna, Q W Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Screening for and identification of novel agents directed at renal cell carcinomaS D Mertins, T G Myers, M Hollingshead, et al.
Molecular Endocrinology (Baltimore, Md.)|June 1, 1988
Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significanceS E Bates, N E Davidson, E M Valverius, et al.
Leukemia|May 24, 2007
Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cellsC Brendel, C Scharenberg, M Dohse, et al.
European Journal of Cancer (Oxford, England : 1990)|January 11, 2011
The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecanO Arnaud, A Boumendjel, A Gèze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapyW H Wilson, C Jamis-Dow, G Bryant, et al.
British Journal of Cancer|April 3, 2008
Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changesA M Calcagno, J M Fostel, K K W To, et al.
Breast Cancer Research and Treatment|September 14, 2016
ANG1005 for breast cancer brain metastases: correlation between <sup>18</sup>F-FLT-PET after first cycle and MRI in response assessmentC C O'Sullivan, M Lindenberg, C Bryla, et al.
Science (New York, N.Y.)|January 17, 1997
An information-intensive approach to the molecular pharmacology of cancerJ N Weinstein, T G Myers, P M O'Connor, et al.
Cancer Research|July 1, 1996
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendationsW T Beck, T M Grogan, C L Willman, et al.
Pageof 11